TU Berlin IMES meets Bayer Pharmaceuticals

In the international and interdisciplinary master's degree program in Innovation Management, Entrepreneurship, and Sustainability (IMES) from the Technische Universität Berlin, students learn about all the fundamental principles of innovation management, entrepreneurship and sustainability. This includes all issues on operative, tactical and strategic levels relevant to founding new businesses or working in R&D. In this meeting with Bayer, IMES will intensify the exchange to leverage knowledge transfer. IMES students will be able to learn from experienced managers first-hand what it means for a multinational corporation to pursue highly relevant topics like sustainability and disruption from technology. https://www.tu.berlin/en/, https://www.tu.berlin/entrepreneurship/forschung-und-lehre/masterstudiengaenge/msc-imes Bayer is an innovation company with a 160-year history, https://www.bayer.com/en/. Our scientific successes are intended to help improve people’s lives. We have multiple programs dedicated exclusively to Innovations, among others, - Collaborate To Cure Hubs, which offer easy-to-access regional partnering interfaces to support biotech and healthcare innovation in these regions, https://www.bayer.com/en/pharma/collaborate-to-cure-hubs - G4A, which partners with healthcare startups and technology companies, https://www.g4a.health/ - Leaps by Bayer, which invests in paradigm-shifting advances in the life sciences, https://leaps.bayer.com/